EUVIMEDSkopri EUVIMED
Open access · CC BY 4.0

Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study

Fiona Mercer iD, Tessa Parkes, Rebecca Foster, Deborah Steven, Andrew McAuley, Alexander Baldacchino, Wez Steele, Joe Schofield, Catriona Matheson iD

Drug and Alcohol Review · 2023-03 · 42 (3) · 517-526

DOI: 10.1111/dar.13554 ↗

At a glance

Journal article in Drug and Alcohol Review, published online on 2022-09-27. Written by Fiona Mercer and 8 co-authors. Institution: Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, UK. Major MEDLINE topics: Opioid-Related Disorders, Pharmacies, Opiate Overdose, Chronic Pain. Cited 5 times so far (Crossref); 35 references. The full text is freely available (open access, CC BY 4.0). Funded by: NHS Fife R&D&I department.

AstrattSubjectsDettalji biblijografiċiCiteRelated studies

Abstract (original language)

Introduction

Despite opioid prescribing for chronic non‐cancer pain (CNCP) having limited therapeutic benefits, recent evidence indicates significant increases in the prescribing of high‐strength opioids for individuals with CNCP. Patients prescribed opioids for CNCP have overdose risk factors but generally have low opioid overdose awareness and low perceptions of risk related to prescribed opioids. Currently, there are few bespoke overdose prevention resources for this group.

Methods

This qualitative study investigated views on a naloxone intervention for people prescribed high‐strength opioids for CNCP delivered via community pharmacies. The intervention included overdose risk awareness and naloxone training and provision. Interviews were conducted with eight patients, four family members and two community pharmacists. Participants were convenience sampled and recruited through networks within the Scottish pain community. The Framework approach was used to analyse findings.

Results

All participants had positive attitudes towards the intervention, but patients and family members considered risk of overdose to be very low. Three themes were identified: potential advantages of the intervention; potential barriers to the intervention; and additional suggestions and feedback about the intervention. Advantages included the intervention providing essential overdose information for CNCP patients. Barriers included resource and time pressures within community pharmacies. Discussion and Conclusion While patients had low overdose knowledge and did not see themselves as being at risk of opioid overdose, they were receptive to naloxone use and positive about the proposed intervention. A feasibility trial is merited to further investigate how the intervention would be experienced within community pharmacy settings.

Subjects

MeSH terms (MEDLINE)

Opioid-Related DisordersPharmaciesOpiate OverdoseChronic PainDrug OverdoseHumansAnalgesics, OpioidNarcotic AntagonistsPharmacistsPractice Patterns, Physicians'Naloxone

Author keywords

chronic non-cancer painnaloxoneoverdose interventionoverdose riskprescription opioids

Substances

Analgesics, OpioidNarcotic AntagonistsNaloxone

Authors and institutions

  • Salvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, UK.
  • NHS Fife, Kirkcaldy, UK.
  • School of Health and Life Sciences, Glasgow Caledonian University, Glasgow, UK.
  • School of Medicine, University of St Andrews, St Andrews, UK.
  • Freelance researcher, Edinburgh, UK.

ORCID profiles: Fiona Mercer, Catriona Matheson

Funding

  • NHS Fife R&D&I department

Cite

APA

Mercer, F., Parkes, T., Foster, R., Steven, D., McAuley, A., Baldacchino, A., Steele, W., Schofield, J., & Matheson, C. (2023). Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study. Drug and Alcohol Review, 42(3), 517-526. https://doi.org/10.1111/dar.13554

Vancouver

Mercer F, Parkes T, Foster R, Steven D, McAuley A, Baldacchino A, et al. Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study. Drug and Alcohol Review. 2023;42(3):517-526. doi:10.1111/dar.13554

BibTeX
@article{Mercer2023,
  author = {Mercer, Fiona and Parkes, Tessa and Foster, Rebecca and Steven, Deborah and McAuley, Andrew and Baldacchino, Alexander and Steele, Wez and Schofield, Joe and Matheson, Catriona},
  title = {Patient, family members and community pharmacists' views of a proposed overdose prevention intervention delivered in community pharmacies for patients prescribed high‐strength opioids for chronic non‐cancer pain: An explorative intervention development study},
  journal = {Drug and Alcohol Review},
  year = {2023},
  volume = {42},
  number = {3},
  pages = {517--526},
  doi = {10.1111/dar.13554}
}
Start for free →